{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T14:06:23Z","timestamp":1726495583739},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","lrjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.leukres.2017.01.022","type":"journal-article","created":{"date-parts":[[2017,1,15]],"date-time":"2017-01-15T15:17:21Z","timestamp":1484493441000},"page":"1-5","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome"],"prefix":"10.1016","volume":"55","author":[{"given":"Hiroki","family":"Hosoi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken-Ichi","family":"Imadome","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinobu","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kodai","family":"Kuriyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shogo","family":"Murata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Mushino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehiro","family":"Oiwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kobata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Nakakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Isobe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouichi","family":"Ohshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Sonoki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.leukres.2017.01.022_bib0005","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/bjh.12788","article-title":"Viral lymphomagenesis: from pathophysiology to the rationale for novel therapies","volume":"165","author":"Castillo","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.01.022_bib0010","doi-asserted-by":"crossref","first-page":"e131","DOI":"10.1038\/emm.2014.84","article-title":"Epstein-Barr virus latent genes","volume":"47","author":"Kang","year":"2015","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.leukres.2017.01.022_bib0015","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1128\/jvi.64.5.2126-2134.1990","article-title":"Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein","volume":"64","author":"Abbot","year":"1990","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2017.01.022_bib0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1053\/j.seminoncol.2014.12.030","article-title":"Epstein-Barr virus-associated lymphomas","volume":"42","author":"Grywalska","year":"2015","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.leukres.2017.01.022_bib0025","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02983236","article-title":"Diagnosis and treatment of Epstein-Barr virus-associated natural killer cell lymphoproliferative disease","volume":"78","author":"Kawa","year":"2003","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.leukres.2017.01.022_bib0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3109\/10428199809059223","article-title":"History and classification of human leukemia-lymphoma cell lines","volume":"31","author":"Drexler","year":"1998","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.leukres.2017.01.022_bib0035","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.leukres.2013.07.033","article-title":"Pyothorax-associated lymphoma (PAL) with biclonal Epstein-Barr virus infection: characterization of a novel PAL cell line with unique features","volume":"37","author":"Taniguchi","year":"2013","journal-title":"Leuk. Res."},{"key":"10.1016\/j.leukres.2017.01.022_bib0040","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.coviro.2013.12.001","article-title":"Epstein Barr virus entry; kissing and conjugation","volume":"4","author":"Shannon-Lowe","year":"2014","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.leukres.2017.01.022_bib0045","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1158\/0008-5472.CAN-03-1562","article-title":"Epstein-Barr virus infection of human natural killer cell lines and peripheral blood natural killer cells","volume":"64","author":"Isobe","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.leukres.2017.01.022_bib0050","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.celrep.2013.01.023","article-title":"Human complement receptor type 1\/CD35 is an Epstein-Barr virus receptor","volume":"3","author":"Ogembo","year":"2013","journal-title":"Cell Rep."},{"key":"10.1016\/j.leukres.2017.01.022_bib0055","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood.V85.2.456.456","article-title":"Model of Epstein-Barr virus infection of human thymocytes: expression of viral genome and impact on cellular receptor expression in the T-lymphoblastic cell line, HPB-ALL","volume":"85","author":"Paterson","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.01.022_bib0060","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1038\/sj.leu.2402519","article-title":"Detection of clonal EBV episomes in lymphoproliferations as a diagnostic tool","volume":"16","author":"Langerak","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.leukres.2017.01.022_bib0065","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1182\/blood.V87.4.1446.bloodjournal8741446","article-title":"Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection","volume":"87","author":"Imai","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.01.022_bib0070","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1128\/jvi.66.5.2689-2697.1992","article-title":"Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts","volume":"66","author":"Brooks","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.leukres.2017.01.022_bib0075","doi-asserted-by":"crossref","first-page":"272","DOI":"10.4049\/jimmunol.127.1.272","article-title":"Isolation of Epstein Barr-virus and studies of its neutralization by human IgG and complement","volume":"127","author":"Nemerow","year":"1981","journal-title":"J. Immunol."},{"key":"10.1016\/j.leukres.2017.01.022_bib0080","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1365-2141.2002.03372.x","article-title":"Epstein-Barr virus-associated T-cell acute lymphoblastic leukaemia","volume":"117","author":"Sakajiri","year":"2002","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.leukres.2017.01.022_bib0085","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein-Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.leukres.2017.01.022_bib0090","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1182\/blood.V85.2.480.480","article-title":"Lack of the expression of EBNA-2 and LMP-1 in T-cell neoplasms possessing Epstein-Barr virus","volume":"85","author":"Suzushima","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.leukres.2017.01.022_bib0095","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1002\/eji.1830180823","article-title":"Expression of CR2\/EBV receptors on human thymocytes detected by monoclonal antibodies","volume":"18","author":"Tsoukas","year":"1988","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.leukres.2017.01.022_bib0100","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/ajh.2830450211","article-title":"CD21 antigen in T-lineage neoplastic lymphoid cells: characteristic expression at thymic stage","volume":"45","author":"Tatsumi","year":"1994","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.leukres.2017.01.022_bib0105","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1093\/intimm\/11.11.1841","article-title":"Expression of CD21 is developmentally regulated during thymic maturation of human T lymphocytes","volume":"11","author":"Fischer","year":"1999","journal-title":"Int. Immunol."}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261730022X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014521261730022X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T20:40:37Z","timestamp":1719002437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014521261730022X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":21,"alternative-id":["S014521261730022X"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2017.01.022","relation":{},"ISSN":["0145-2126"],"issn-type":[{"type":"print","value":"0145-2126"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Epstein-Barr virus susceptible immature T-cell line, WILL4, established from a patient with T-lymphoblastic lymphoma bearing CD21 and a clonal EBV genome","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2017.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}